Carol Kao

1.3k total citations
28 papers, 337 citations indexed

About

Carol Kao is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Carol Kao has authored 28 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 12 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Carol Kao's work include Kawasaki Disease and Coronary Complications (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Respiratory viral infections research (5 papers). Carol Kao is often cited by papers focused on Kawasaki Disease and Coronary Complications (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Respiratory viral infections research (5 papers). Carol Kao collaborates with scholars based in United States, Argentina and China. Carol Kao's co-authors include Evan J. Anderson, Walter A. Orenstein, Preeti Jaggi, Mehgan Teherani, İnci Yıldırım, Stephanie A. Fritz, Christina A. Rostad, Joseph A. Bocchini, W. Matthew Linam and Shanmuganathan Chandrakasan and has published in prestigious journals such as PEDIATRICS, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Carol Kao

27 papers receiving 332 citations

Peers

Carol Kao

SURGE

EPIDE

HEALT

Han Wool Kim South Korea

Christiana Smith United States

Tuğba Bedir Demirdağ Türkiye

Tulika Singh United States

Sunanda Gaur United States

Maria Cristina Rota Italy

Athanasios Kossyvakis Greece

Roberto Posada United States

David Leeman United Kingdom

Diego R. Hijano United States

Han Wool Kim South Korea

Carol Kao

169 ×0.9

34 ×0.4

SURGE

165 ×1.8

EPIDE

32 ×0.6

HEALT

51 ×1.2

Citations per year, relative to Carol Kao Carol Kao (= 1×) peers Han Wool Kim

Countries citing papers authored by Carol Kao

Since Specialization

Citations

This map shows the geographic impact of Carol Kao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Kao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Kao more than expected).

Fields of papers citing papers by Carol Kao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Kao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Kao. The network helps show where Carol Kao may publish in the future.

Co-authorship network of co-authors of Carol Kao

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Kao. A scholar is included among the top collaborators of Carol Kao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Kao. Carol Kao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kao, Carol. (2024). Overview of COVID-19 Infection, Treatment, and Prevention in Children. Journal of Clinical Medicine. 13(2). 424–424. 2 indexed citations

Kao, Carol, Christina A. Rostad, L. Nolan, et al.. (2024). A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US Adults. The Journal of Infectious Diseases. 230(5). 1093–1101. 9 indexed citations

Godfred‐Cato, Shana, Amber Kunkel, Ami B. Shah, et al.. (2024). Long-term Health Outcomes After Hospital Discharge Among Children Hospitalized for MIS-C or COVID-19, September 29, 2021, to June 21, 2022. The Pediatric Infectious Disease Journal. 43(11). 1074–1082. 2 indexed citations

Evans, Amanda S., Charuta Joshi, Laura Filkins, et al.. (2024). Examining Clinical Features and Severe Neurologic Disease of Parechovirus Infection in Young Infants: A Multistate Cohort Study. Clinical Infectious Diseases. 79(6). 1479–1486. 1 indexed citations

Anderson, Larry J., Samadhan Jadhao, Laila Hussaini, et al.. (2024). Development and comparison of immunologic assays to detect primary RSV infections in infants. Frontiers in Immunology. 14. 1332772–1332772. 4 indexed citations

Kao, Carol & Stephanie A. Fritz. (2024). Infection prevention—how can we prevent transmission of community-onset methicillin-resistant Staphylococcus aureus?. Clinical Microbiology and Infection. 31(2). 166–172. 6 indexed citations

Hsiao, Hui‐Mien, Xuemin Chen, Amber Kunkel, et al.. (2023). Serologic responses to COVID-19 vaccination in children with history of multisystem inflammatory syndrome (MIS-C). Vaccine. 41(17). 2743–2748. 3 indexed citations

Kao, Carol & Marian G. Michaels. (2023). Approach to vaccinating the pediatric solid organ transplant candidate and recipient. Frontiers in Pediatrics. 11. 1271065–1271065. 2 indexed citations

Yousaf, Anna R, Amber Kunkel, Joseph Y. Abrams, et al.. (2022). COVID-19 Vaccine Reactogenicity and Vaccine Attitudes Among Children and Parents/Guardians After Multisystem Inflammatory Syndrome in Children or COVID-19 Hospitalization: September 2021—May 2022. The Pediatric Infectious Disease Journal. 42(3). 252–259. 8 indexed citations

10.

Kao, Carol, et al.. (2022). Management and Prevention of Staphylococcus aureus Infections in Children. Infectious Disease Clinics of North America. 36(1). 73–100. 16 indexed citations

11.

Rostad, Christina A., Ann Chahroudi, Grace Mantus, et al.. (2020). Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C). PEDIATRICS. 146(6). 84 indexed citations

12.

Teherani, Mehgan, Carol Kao, Andrés Camacho-González, et al.. (2020). Burden of Illness in Households With Severe Acute Respiratory Syndrome Coronavirus 2–Infected Children. Journal of the Pediatric Infectious Diseases Society. 9(5). 613–616. 20 indexed citations

13.

Anderson, Evan J., Lilin Lai, Jens Wrammert, et al.. (2020). Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine. Vaccines. 8(1). 69–69. 5 indexed citations

14.

Kao, Carol, Walter A. Orenstein, & Evan J. Anderson. (2020). The Importance of Advancing Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Children. Clinical Infectious Diseases. 72(3). 515–518. 33 indexed citations

15.

Chandrakasan, Shanmuganathan, et al.. (2020). Severe Pediatric COVID-19 Presenting With Respiratory Failure and Severe Thrombocytopenia. PEDIATRICS. 146(1). 36 indexed citations

16.

Kao, Carol, Marianne E. Yee, Kristina Lai, et al.. (2020). Microbiology and radiographic features of osteomyelitis in children and adolescents with sickle cell disease. Pediatric Blood & Cancer. 67(10). e28517–e28517. 6 indexed citations

17.

Anderson, Evan J., Benjamin A. Lopman, Jumi Yi, et al.. (2019). Effect of Concomitant Antibiotic and Vaccine Administration on Serologic Responses to Rotavirus Vaccine. Journal of the Pediatric Infectious Diseases Society. 9(4). 479–482. 2 indexed citations

18.

Kao, Carol, Clare Burn Aschner, William R. Jacobs, & Betsy C. Herold. (2017). Maternal Immunization with a Single-Cycle Herpes Simplex Virus (HSV) Candidate Vaccine, ΔgD-2, Protects Neonatal Mice from Lethal Viral Challenge. Open Forum Infectious Diseases. 4(suppl_1). S22–S22. 2 indexed citations

19.

Kao, Carol & David L. Goldman. (2016). Cryptococcal Disease in HIV-Infected Children. Current Infectious Disease Reports. 18(9). 27–27. 9 indexed citations

20.

Kao, Carol, et al.. (2014). Child and adolescent immunizations. Current Opinion in Pediatrics. 26(3). 383–395. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact